| scholarly article | Q13442814 |
| P2093 | author name string | K. Soltani | |
| J. E. Bernstein | |||
| D. H. Whitney | |||
| P2860 | cites work | Itching: the pathophysiology of pruritus | Q34035271 |
| H2-receptor antagonists in perspective | Q38155111 | ||
| Tricyclic antidepressants block histamine H1 receptors of mouse neuroblastoma cells | Q39197698 | ||
| Histamine H 1 Receptor-Mediated Guanosine 3′,5′-Monophosphate Formation by Cultured Mouse Neuroblastoma Cells | Q39198140 | ||
| Histamine (second of two parts). | Q39363739 | ||
| The efficacy of antidepressant drugs. A review of research (1958-1972). | Q39962052 | ||
| Suppression of histamine-induced pruritus by three antihistaminic drugs*1 | Q40306600 | ||
| Brain biogenic amine depletion and mood | Q44609942 | ||
| Definition and antagonism of histamine H 2 -receptors | Q46704110 | ||
| Biogenic amines and depression. Biochemical and pharmacological separation of two types of depression | Q67348226 | ||
| Diseases of the skin. The management of pruritus | Q70041207 | ||
| Experimental histamine pruritus. III. Influence of drugs on the itch threshold | Q73381935 | ||
| Pain threshold measurements on human skin following application of topical analgesics | Q75746687 | ||
| Experimental histamine pruritus. I. Influence of physical and psychological factors on threshold reactivity | Q76225797 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | dermatology | Q171171 |
| P304 | page(s) | 582-585 | |
| P577 | publication date | 1981-11-01 | |
| P1433 | published in | Journal of the American Academy of Dermatology | Q15757046 |
| P1476 | title | Inhibition of histamine-induced pruritus by topical tricyclic antidepressants | |
| P478 | volume | 5 |
| Q39730278 | A review of pruritus |
| Q37720689 | Bottlenecks in the development of topical analgesics: molecule, formulation, dose-finding, and phase III design |
| Q34710327 | Comparison of cinnarizine, cyproheptadine, doxepin, and hydroxyzine in treatment of idiopathic cold urticaria: usefulness of doxepin |
| Q41119577 | Cutaneous sensory disorder |
| Q40113106 | Dermatologic therapy: December, 1980, through November, 1981 |
| Q57311816 | Dermatotherapeutic Agents |
| Q70843809 | Effect of topical doxepin cream on skin testing |
| Q40245260 | Pharmacologic control of pruritus. |
| Q89631380 | Protective effects of doxepin cream on radiation dermatitis in breast cancer: A single arm double-blind randomized clinical trial |
| Q41119587 | Psychopharmacology for dermatologic patients |
| Q33290606 | Psychophysical and physiological evidence for parallel afferent pathways mediating the sensation of itch. |
| Q40877917 | Psychotropic agents in dermatology. |
| Q34999585 | Psychotropic and neurotropic agents in dermatology: unapproved uses, dosages, or indications |
| Q39481025 | Relief of pruritus in patients with atopic dermatitis after treatment with topical doxepin cream. The Doxepin Study Group |
| Q70843423 | Self-potentiating allergic contact dermatitis caused by doxepin hydrochloride cream |
| Q28373124 | The addition of topical doxepin to corticosteroid therapy: an improved treatment regimen for atopic dermatitis |
| Q84281484 | [Antidepressant drugs : a reasonable therapy for pruritus?] |
Search more.